Because of its unique localization and pleiotropic roles, DHODH is frequently upregulated in malignancies, including colorectal cancer, hepatocellular carcinoma, glioblastoma, breast cancer, and renal cell carcinoma [13,15,16,17]. This evidence concerns the gene DHODH and hepatocellular carcinoma.